Balaxi Pharmaceuticals Limited
BALAXI.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.23B
Close$
Share Statistics
| Market cap | $1.23 Billion |
|---|---|
| Enterprise Value | $1.66 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.26 |
| Beta | 0.72 |
| Outstanding Shares | 55,207,500 |
Return
| Return on Equity | 0.97% |
|---|---|
| Return on Assets | 0.72% |
| Return on Invested Capital | 2.76% |
Valuation & Multiples
| P/E Ratio | 49.62 |
|---|---|
| PEG | 14.29 |
| Price to Sales | 0.44 |
| Price to Book Ratio | 0.49 |
| Enterprise Value to Revenue | 0.59 |
| Enterprise Value to EBIT | 19.84 |
| Enterprise Value to Net Income | 68 |
| Total Debt to Enterprise | 0.35 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Balaxi Pharmaceuticals Limited
51 employees
CEO: Ashish Maheshwari Balaxi Pharmaceuticals Limited, through its entity Balaxi Ventures Ltd., primarily operates as an international wholesale distributor specializing in pharmaceuticals, various food items, and hardware supplies. The company's corporate bas...